Digital Marketing Trends in Human Immunodeficiency Virus (HIV) – ResearchAndMarkets.com – businesswire.com

DUBLIN–(BUSINESS WIRE)–The “Digital Marketing Trends in Human Immunodeficiency Virus (HIV)” report has been added to ResearchAndMarkets.com’s offering.

Gilead’s Biktarvy.com achieved the highest traffic across branded HIV patient sites in the US from April 2021 to March 2022, with about 3,800,000 visits, followed by ViiV’s Dovato.com and Gilead’s Descovy.com. The highest proportion of traffic to these sites originated from direct sources, followed by referrals. Websites for several brands, including Descovy, Cabenuva, Truvada, and Pifeltro, had similar levels of high direct traffic (53-57%), while Janssen’s Symtuza.com had the lowest (34%).

For patient branded sites, Gilead spent the most on DDA for Biktarvy.com at $20.5 million, followed by Gilead’s Descovy.com at $3.6 million and ViiV’s Dovato.com at $2.3 million. Descovy.com was supported by the most paid keywords at approximately 10,200 keywords, followed by Biktarvy.com at about 5,900 keywords.

For branded HCP sites in the…

Read Full Story: https://www.businesswire.com/news/home/20221010005376/en/Digital-Marketing-Trends-in-Human-Immunodeficiency-Virus-HIV—ResearchAndMarkets.com

The post Digital Marketing Trends in Human Immunodeficiency Virus (HIV) – ResearchAndMarkets.com – businesswire.com first appeared on SEO, Marketing and Social News | OneSEOCompany.com.

source: https://news.oneseocompany.com/2022/10/10/digital-marketing-trends-in-human-immunodeficiency-virus-hiv-researchandmarketscom-businesswirecom_2022101032706.html

Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.